59
Participants
Start Date
August 31, 2010
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Lacosamide
"Subjects randomized to lacosamide according to the following schedule:~Treatment Phase Week Dose Week 1 LCM 50 mg bid Week 2 LCM 100 mg bid Week 3 LCM 150 mg bid Week 4 LCM 200 mg bid"
Placebo
Placebo will be packaged identically to experimental drug and titrated according to the same schedule.
Cleveland Clinic, Cleveland
Collaborators (1)
UCB Pharma
INDUSTRY
The Cleveland Clinic
OTHER